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Supplementary Figure 1: Experimental Design
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Figure S4 part 1
Supplementary Figure 4: Interferon signaling in lungs and blood induced in hamsters after SARS-CoV-2 infection
(a), Dotplot of enriched terms from hallmark, reactome and gene ontology (biological process) gene sets in lung bulk RNA-sequencing 
samples over the infection time course compared to naïve animals. Coloration and point size indicate effect size and P value for each 
time point (2, 3, 5 and 14 days post infection, pi), relative to control groups (naïve), as calculated by tmod. (b), as in (a) but for blood 
samples. (c), Heatmap of interferon type I and interferon gamma related genes as in (Winkler et al., 2020) in lungs over the infection time 
course. Normalized average gene expression levels (z-scores) are indicated by coloration for each animal. (d), as in (c), but for blood 
samples. Normalized average gene expression levels are indicated by coloration for each animal, n = 2 for blood samples of day 5 pi, n 
= 3 for all other time points. (e) Magnitude of host response over time as fraction (in %) of differentially regulated proteins (p-values < 
0.01). (f), Correspondence of differentially expressed genes in proteomic and bulk RNA sequencing data was explored by linear regres-






































































































































































































































Figure S5, part 1






































































































































































































































































































































































































































































































































































































































































Supplementary Figure 5: Transcriptional response to SARS-CoV-2 infection is 
strongest in myeloid and endothelial cells
(a), Dotplot of differentially expressed genes in lungs. Shown are genes that are in 
at least one cell type among the top 15 most changing genes as ranked by adjusted 
p value. Coloration and point size indicate log2-transformed fold changes and p 
values, respectively, of genes at 2 dpi time point relative to control groups (naïve). 
Adjusted p values were calculated by DEseq2 using Benjamini-Hochberg correc-
tions of Wald test p values. (b), as in (a), but for blood samples. (c), Scatter plot 
showing differential expression in monocytes / monocytic macrophages of lungs 
compared to blood. Plotted are log(2) transformed fold changes from naïve (horizon-
tal axis) and 2 day infected (vertical axis) animals. Outliers deregulated only in lungs 
are shown in red, outliers deregulated only in the blood in green. (d), Top, fraction of 
AT2 and monocytic macrophages from all time points in lung samples expressing 
Mx2 and Cxcl10. Bottom, boxplots of gene expression values of the cells positive for 
Mx2 (left) and Cxcl10 (right). (e), Boxplots show expression of, from left to right, 
ISG15, MX2, CXCL10 and CCL2 in patient BAL data from (Liao et al., 2020) in the 
indicated cell types. Patient categories (healthy, moderate and severe) according to 
the original publication. (f), Scatter plot of log2-transformed fold changes of gene 
expression values of classical monocytes in BAL data from (Liao et al., 2020) 
(severe COVID-19 patients compared to healthy individuals, horizontal axis), and 
monocytic macrophages from hamsters (5 dpi compared to naïve, vertical axis).
For barplots, data display means ± SD. n = 3 per time point. For boxplots, lower and 
upper hinges correspond to first and third quartiles. Whiskers extend to a maximum 
of 1.5 times distance between first and third quartile. Outliers beyond are marked by 
single dots.
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Supplementary Figure 6: Strong transcriptional response in 
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Supplementary Figure 7: TLR signaling is activated in 
monocytic macrophages containing viral RNA
(a), Dotplot of differentially expressed inflammatory media-
tors of monocytic macrophages containing viral RNA com-
pared to monocytic macrophages not containing viral RNA. 
Coloration and point size indicate log2 fold change and P 
5
with viral RNA compared to those without. (b), GO and 









































































































































































































































































































































































































































Supplementary Figure 8: Transcriptional 
response of endothelial subtypes to 
SARS-CoV-2 infection
(a), Heatmap of cell type-marker gene expres-
sion in identified clusters for endothelial cell 
subtypes, based on classical cell type-markers. 
Normalized average gene expression levels for 
cells in a cluster are indicated by coloration. (b), 
Percentage of lung endothelial cell subpopula-
tions for each time point (2, 3, 5 and 14 dpi) and 
control groups (naïve). Data display means and 
individual values ± SD, n = 3 per time point. (c) 
Dotplot of differentially expressed genes in 
endothelial cell subtype. Shown are genes that 
are in at least one cell type among the top 50 
most changing genes as ranked by adjusted p 
value (only events with adjusted p value larger 
0.01). Coloration and point size indicate 
log2-transformed fold changes and p values, 
respectively, of genes at 2 dpi time point relative 
to control groups (naïve). Adjusted p values 
were calculated by DEseq2 using Benjami-

















































































































































































































































































































































































































































































































Supplementary Figure 9: Transcriptional response 
of T and NK cells to SARS-CoV-2 infection
(a), Heatmap of cell type-marker gene expression in 
identified clusters for T and NK cell subtypes, based on 
classical cell type-markers. Normalized average gene 
expression levels for cells in a cluster are indicated by 
coloration. (b) Dotplot of differentially expressed genes 
in T and NK cell subtype. Shown are genes that are in 
at least one cell type among the top 50 most changing 
genes as ranked by adjusted p value (only events with 
adjusted p value larger 0.01). Coloration and point size 
indicate log2-transformed fold changes and p values, 
respectively. Adjusted p values were calculated by 
DEseq2 using Benjamini-Hochberg corrections of Wald 
test p values.
Table S1: Oligonucleotides used in this study. 
Primer/probe Sequence 5’–3’ 
SARS-CoV-2 forward ACAGGTACGTTAATAGTTAATAGCGT 
SARS-CoV-2 reverse ATATTGCAGCAGTACGCACACA 
SARS-CoV-2 probe FAM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ 
RPL-18 forward GTTTATGAGTCGCACTAACCG 
RPL-18 reverse TGTTCTCTCGGCCAGGAA 
RPL-18 probe FAM-TCTGTCCCTGTCCCGGATGATC-BHQ 
 
 
Table S2. Identified proteins in respective proteome analysis 
Differentially regulated in lung 
and reported to be regulated in 
human BAL fluid (22 proteins) 
  Showing the same direction of change (10 proteins)   
Differentially regulated proteins 
in lung that have been reported 
to be regulated in human plasma 
(13 proteins) 
Sept11 Ctsz  Sept11   C4b  
Sod2 Grb2  Sod2   Ace  
Hspa5 Eif6  Hspa5   S100a8  
Tppp3 Gprc5a  Tppp3   Serpind1  
Galm Rps19  Galm   Ighm  
Csrp1 Lap3  Csrp1   Hp  
Dpysl2 Cd9  Dpysl2   B2m  
Vat1 Samhd1  Vat1   Hpx  
Igkv7-33 Aqp5  Igkv7-33   Itih3  
Lgals3bp  Lgals3bp  Serping1  
Cotl1      Igkv7-33  
Pls3      Cfi  
Psme1      Lgals3bp  
        
        
Showing the same trend (9 
proteins)   
Differentially expressed in serum 
(37 proteins)   
Proteins reported in human 
COVID19 studies (20 proteins) 
S100a8   Apoc1 Cfd  Apoc1 Actg1 
Ighm   Cetp Aldh1a1  C4b  
Hp   C4b Pon1  Gsn  
B2m   Smco3   C6  
Itih3   Gsn Apoc3  Apoa1  
Serping1  C6 Mbl1  Clu  
Igkv7-33   Apoa1 Clec3b  Serping1  
Cfi   Hbae5 Hpx  Hp  
Lgals3bp  Igkv7-33   Hpx  
   Clu Hbb-y  Lbp  
   Serping1 Agt  Itih3  
   Hp Calb1  Rbp4  
   Adipoq Actg1  Ttr  
   Dusp2 Amy1  Cfd  
   Pltp Aldob  Pon1  
   Cndp1 ENSMAUG00000021094  Apoc3  
   Lbp ENSMAUG00000016284  Clec3b  
   Itih3 ENSMAUG00000001023  Igkv7-33  
   Rbp4 ENSMAUG00000004376  Agt  
   Ttr     






















1Data are represented as mean±standard deviation. Ace2, Angiotensin-converting enzyme 2, Tmprss2, transmembrane serine protease 2, Bsg, Basigin, Nrp1, neutropilin, Ext1 heparan sulfate, 
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, dpi, days post infection 
Gene Day (d)  Alveolar epithelial 
cells type 1 
Alveolar epithelial 














  0 dpi (naïve) 0.43±0.74 3.70±1.20 21.82±13.73 0.06±0.11 0.00 1.10±0.36 0.28±0.34 1.38±1.59 
  2 dpi 0.98±1.70 3.79±1.00 4.44±7.70 0.00 0.00 1.09±0.58 0.30±0.19 0.50±0.86 
  3 dpi 0.67±1.15 3.53±1.24 10.13±8.77 0.00 0.00 0.90±0.23 0.23±0.21 0.46±0.80 
  5 dpi 0.00 4.83±1.52 0.00 0.00 0.00 0.14±0.25 0.25±0.16 1.10±1.28 





  0 dpi (naïve) 73.68±5.59 12.00±1.86 34.55±14.43 0.13±0.11 0.00 0.00 0.06±0.11 0.00 
  2 dpi 44.91±8.72   5.76±0.66 27.29±14.75 0.11±0.19 0.00 0.07±0.12 0.24±0.26 0.00 
  3 dpi 54.25±5.04   9.30±1.66 27.14±5.45 0.00 0.50±0.86 0.13±0.11 0.09±0.08 0.00 
  5 dpi 56.19±18.23 11.98±2.16   6.58±7.93 0.00 0.00 0.14±0.25 0.08±0.07 0.00 




  0 dpi (naïve) 30.63±1.02 16.55±3.07 29.29±9.74 18.95±1.20 10.50±5.86 10.21±2.47 25.95±1.46 18.75±6.56 
  2 dpi 28.69±6.20 16.74±3.98 31.00±8.89 17.28±0.91 18.77±2.99 13.57±2.99 23.90±6.26 16.45±6.63 
  3 dpi 34.97±4.62 22.97±2.42 26.24±9.55 19.09±0.99 16.61±8.21 12.58±1.10 28.69±0.55 19.72±5.95 
  5 dpi 24.11±12.96 22.74±5.35   6.58±7.93 22.19±0.79 17.62±2.39 40.03±9.12 52.76±4.78 51.63±1.61 
14 dpi 30.71±5.03 20.67±1.69 42.16±11.14 19.31±0.91 14.13±5.82 12.32±4.06 26.70±5.07 25.16±8.76 
Bs
g 
  0 dpi (naïve) 100.0±0.00 93.93±1.35 96.97±5.25 94.36±3.50 96.07±2.40 95.10±1.37 76.55±7.16 83.81±3.96 
  2 dpi 99.49±0.89 90.65±4.77 95.21±4.18 92.69±5.16 96.92±2.07 92.28±4.19 77.19±7.13 84.03±9.83 
  3 dpi 98.73±1.11 92.80±0.95 96.30±6.42 95.12±2.42 98.71±1.20 93.39±1.62 80.17±1.03 85.90±2.87 
  5 dpi 100.00±0.00 99.46±0.93 92.34±7.20 99.24±1.10 100.00±0.00 91.50±2.72 92.23±1.11 97.43±1.53 




  0 dpi (naïve) 0.44±0.76 32.06±6.04 4.14±4.60 54.92±10.61 12.65±3.25 0.25±0.44 1.40±0.65 7.81±7.34 
  2 dpi 0.90±0.80 32.99±5.15 1.28±2.22 45.48±9.69 10.75±5.14 0.22±0.37 2.18±0.98 6.43±4.89 
  3 dpi 0.95±1.65 41.46±7.27 1.67±2.89 57.70±5.56 19.76±12.25 0.32±0.56 1.97±0.68 6.98±2.44 
  5 dpi 0.72±1.26 35.24±4.96 8.96±5.74 55.25±8.27 10.16±5.77 12.33±6.84 16.66±2.06 34.58±15.48 




  0 dpi (naïve) 22.43±3.37 12.37±1.46 5.25±4.71 8.14±1.62 20.62±6.23 17.74±2.64 6.81±1.25 8.14±1.20 
  2 dpi 12.66±5.06   9.73±3.97 9.97±11.29 7.38±3.38 17.89±4.81 11.46±2.73 7.48±1.39 8.75±4.24 
  3 dpi 17.70±7.72 12.37±1.85 33.65±20.33 11.76±0.53 35.84±12.53 16.41±2.84 12.86±1.65 10.97±2.54 
  5 dpi 19.89±7.84 15.24±5.47 8.36±8.71 9.06±1.21 25.12±0.59 22.93±5.25 27.84±1.82 27.74±4.85 







   2 dpi   6.01±7.89   6.41±6.55   6.07±5.79 4.95±5.91   4.46±6.70 7.85±6.82 10.24±6.67 9.39±7.33 
  3 dpi 10.48±13.31 12.05±6.41 15.50±4.45 9.15±7.70 10.05±6.01 12.20±8.66 11.47±7.40 15.76±11.03 
  5 dpi   4.17±7.22   2.76±3.91   7.84±0.79 1.88±1.63   2.14±2.52 24.77±0.31 9.65±2.32 15.74±5.02 
14 dpi 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Supplementary Figure legends 54 
 55 
Supplementary Figure 1: Experimental Design 56 
 57 
Supplementary Figure 2: Course of SARS-CoV-2 infection in Syrian hamsters. 58 
(a), Relative body weight curve of hamsters recorded up to 14 days post infection (dpi). 59 
(b), Virus titers in lung homogenates titrated on Vero E6 cells. Dotted line represents 60 
limit of detection. (c), SARS-CoV-2 genomic RNA copies in lung tissue per 105 cellular 61 
Rpl18 transcripts and (d), RNA copies per bucco-pharyngeal swab. (e), whole cross 62 
sectional scans of left lung lobes of naïve (left) or SARS-CoV-2 infected hamsters at 2 63 
to 14 dpi. Bar: 1 mm. (f-k), Histopathology at higher magnifications (representative 64 
images of haematoxylin and eosin stains) identified suppurative bronchitis at 2 dpi (f, 65 
asterisks) with intraluminal neutrophils (g, arrows) and early bronchointerstitial 66 
pneumonia with necrosis of bronchial epithelial cells at 3 dpi (g, arrowheads). At 3 dpi, 67 
high numbers of neutrophils and macrophages in alveolar lumina of peripheral lung 68 
parenchyma (h; inset: neutrophils, arrowhead and macrophages, arrow). At 5 dpi (i), 69 
stronger immune cell influxes accompanied by hyperplasia of alveolar (arrows) and 70 
bronchial epithelial cells (inset, double headed arrow). Alveolar (j, asterisk) and 71 
perivascular edema (j inset, hash) at 5 dpi. (k) At 14 dpi, inflammation still present 72 
albeit weaker, hyperplasia of alveolar epithelial cells, clearance of alveolar edema and 73 
re-ventilation of alveolar lumina. f = 200 µm, g – k = 50 µm, inset h = 20 µm, inset i = 74 
50 µm, inset j = 100 µm. (l - n) histopathology scores: parameters were classified (0 75 
absent – 4 severe) and summarized as published (Osterrieder et al., 2020; Schauer et 76 
al., 2017) with modifications: (l), lung inflammation score including: severity of 77 
pulmonary inflammation, bronchitis, bronchial necrosis, alveolar necrosis, hyperplasia 78 
of alveolar epithelial cells type II, bronchial epithelial hyperplasia and endothelitis. (m), 79 
edema score: alveolar and perivascular edema. (n), immune cell influx: neutrophils, 80 
macrophages and lymphocytes. (a) Mean ± standard deviation (SD), (b – d) and (l – 81 
n), Boxplots depicting median, individual values and whiskers (minimum to maximum), 82 





Supplementary Figure 3: Transient leukopenia induced by SARS-CoV-2 in blood 88 
of hamsters 89 
(a), Heatmap of cell type-marker gene expression in identified clusters for lung cells, 90 
based on classical cell type-markers. Normalized average gene expression levels for 91 
cells in a cluster are indicated by coloration. (b), Changes in cellular component density 92 
in UMAP projection over the infection time course. Coloration indicates the log2 fold 93 
change for each time point (2, 3, 5 and 14 dpi), relative to control groups (naïve). (c 94 
and d), Number and percentage of cellular components for each time point pi per lung 95 
lobe. (e), Heatmap of cell type-marker gene expression in identified clusters for blood 96 
cells, based on classical cell type-markers. Normalized average gene expression 97 
levels for cells in a cluster are indicated by coloration. (f), Number of cellular 98 
components for each time point pi per mL blood. (a, b and e), Clusters defined by 99 
Louvain clustering, n = 3 per time point. (c, d and f), Data display means ± SD. n = 3 100 
per time point. Ordinary one-way ANOVA, Sidak’s multiple comparisons test versus 101 
corresponding 0 dpi (naïve). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 102 
 103 
Supplementary Figure 4: Interferon signaling in lungs and blood induced in 104 
hamsters after SARS-CoV-2 infection 105 
(a), Dotplot of enriched terms from hallmark, reactome and gene ontology (biological 106 
process) gene sets in lung bulk RNA-sequencing samples over the infection time 107 
course compared to naïve animals. Coloration and point size indicate effect size and 108 
P value for each time point (2, 3, 5 and 14 days post infection, pi), relative to control 109 
groups (naïve), as calculated by tmod. (b), as in (a) but for blood samples. (c), Heatmap 110 
of interferon type I and interferon gamma related genes as in (Winkler et al., 2020) in 111 
lungs over the infection time course. Normalized average gene expression levels (z-112 
scores) are indicated by coloration for each animal. (d), as in (c), but for blood samples. 113 
Normalized average gene expression levels are indicated by coloration for each 114 
animal, n = 2 for blood samples of day 5 pi, n = 3 for all other time points. (e) Magnitude 115 
of host response over time as fraction (in %) of differentially regulated proteins (p-116 
values < 0.01). (f), Correspondence of differentially expressed genes in proteomic and 117 
bulk RNA sequencing data was explored by linear regression (intersection at 0) of log 118 
transformed fold changes of infected vs control (5 dpi, p.value < 0.01). Linear fit 119 
showed almost ideal consistensy between regulations (slope = 0.8) and a correlation 120 
coefficient r = 0.9 (r2 = 0.82). 121 
 122 
Supplementary Figure 5: Transcriptional response to SARS-CoV-2 infection is 123 
strongest in myeloid and endothelial cells 124 
(a), Dotplot of differentially expressed genes in lungs. Shown are genes that are in at 125 
least one cell type among the top 15 most changing genes as ranked by adjusted p 126 
value. Coloration and point size indicate log2-transformed fold changes and p values, 127 
respectively, of genes at 2 dpi time point relative to control groups (naïve). Adjusted p 128 
values were calculated by DEseq2 using Benjamini-Hochberg corrections of Wald test 129 
p values. (b), as in (a), but for blood samples. (c), Scatter plot showing differential 130 
expression in monocytes / monocytic macrophages of lungs compared to blood. 131 
Plotted are log(2) transformed fold changes from naïve (horizontal axis) and 2 day 132 
infected (vertical axis) animals. Outliers deregulated only in lungs are shown in red, 133 
outliers deregulated only in the blood in green. (d), Top, fraction of AT2 and monocytic 134 
macrophages from all time points in lung samples expressing Mx2 and Cxcl10. Bottom, 135 
boxplots of gene expression values of the cells positive for Mx2 (left) and Cxcl10 (right). 136 
(e), Boxplots show expression of, from left to right, ISG15, MX2, CXCL10 and CCL2 in 137 
patient BAL data from (Liao et al., 2020) in the indicated cell types. Patient categories 138 
(healthy, moderate and severe) according to the original publication. (f), Scatter plot of 139 
log2-transformed fold changes of gene expression values of classical monocytes in 140 
BAL data from (Liao et al., 2020) (severe COVID-19 patients compared to healthy 141 
individuals, horizontal axis), and monocytic macrophages from hamsters (5 dpi 142 
compared to naïve, vertical axis). 143 
For barplots, data display means ± SD. n = 3 per time point. For boxplots, lower and 144 
upper hinges correspond to first and third quartiles. Whiskers extend to a maximum of 145 
1.5 times distance between first and third quartile. Outliers beyond are marked by 146 
single dots. 147 
 148 
Supplementary Figure 6: Strong transcriptional response in monocytic 149 
macrophages from hamsters is recapitulated in human patient data 150 
(a), Dotplot of log2-transformed fold changes of gene expression values in cell types 151 
from upper airway samples from (Chua et al., 2020) (COVID-19 patients compared to 152 
healthy individuals). (b), Dotplot of average gene expression values in cell types only 153 
present in COVID-19 patients from upper airway samples from Chua et al. Cell types 154 
are defined as following – Bcell: B cells; MoD-Ma: monocyte-derived macrophage; 155 
moDC: monocyte-derived dendritic cell; Neu: Neutrophil; NKT: NKT cell; Basal: basal 156 
cells; Ciliated: ciliated cells; Ciliated-diff: Differentiating ciliated cells; CTL: Cytotoxic T 157 
cell; IRC: IFNG responsive cell; NKT-p: Proliferating NKT cell; nrMa: Non-resident 158 
macrophage; rMa: Resident macrophage; Secretory: secretory cells; Secretory-diff: 159 
differentiating decretory cells; Squamous: squamous cells; Treg: Regulatory T cell. 160 
 161 
Supplementary Figure 7: TLR signaling is activated in monocytic macrophages 162 
containing viral RNA 163 
(a), Dotplot of differentially expressed inflammatory mediators of monocytic 164 
macrophages containing viral RNA compared to monocytic macrophages not 165 
containing viral RNA. Coloration and point size indicate log2 fold change and P value 166 
of genes at each time point (2, 3 and 5 dpi) of cells with viral RNA compared to those 167 
without. (b), GO and KEGG pathway term enrichment of the gene sets defined in (a). 168 
 169 
Supplementary Figure 8: Transcriptional response of endothelial subtypes to 170 
SARS-CoV-2 infection 171 
(a), Heatmap of cell type-marker gene expression in identified clusters for endothelial 172 
cell subtypes, based on classical cell type-markers. Normalized average gene 173 
expression levels for cells in a cluster are indicated by coloration. (b), Percentage of 174 
lung endothelial cell subpopulations for each time point (2, 3, 5 and 14 dpi) and control 175 
groups (naïve). Data display means and individual values ± SD, n = 3 per time point. 176 
(c) Dotplot of differentially expressed genes in endothelial cell subtype. Shown are 177 
genes that are in at least one cell type among the top 50 most changing genes as 178 
ranked by adjusted p value (only events with adjusted p value larger 0.01). Coloration 179 
and point size indicate log2-transformed fold changes and p values, respectively, of 180 
genes at 2 dpi time point relative to control groups (naïve). Adjusted p values were 181 
calculated by DEseq2 using Benjamini-Hochberg corrections of Wald test p values. 182 
 183 
Supplementary Figure 9: Transcriptional response of T and NK cells to SARS-184 
CoV-2 infection 185 
(a), Heatmap of cell type-marker gene expression in identified clusters for T and NK 186 
cell subtypes, based on classical cell type-markers. Normalized average gene 187 
expression levels for cells in a cluster are indicated by coloration. (b) Dotplot of 188 
differentially expressed genes in T and NK cell subtype. Shown are genes that are in 189 
at least one cell type among the top 50 most changing genes as ranked by adjusted p 190 
value (only events with adjusted p value larger 0.01). Coloration and point size indicate 191 
log2-transformed fold changes and p values, respectively. Adjusted p values were 192 
calculated by DEseq2 using Benjamini-Hochberg corrections of Wald test p values. 193 
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